Hsbc Holdings PLC Cullinan Oncology, Inc. Transaction History

Hsbc Holdings PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$7.89 - $10.23 $465 - $603	-59 Reduced 0.27%	21,816 $222,000
Q3 2023 Nov 13, 2023	BUY	$9.05 - $11.72 $197,968 - $256,375	21,875 New	21,875 $197,000
Q1 2023 May 15, 2023	SELL	$10.2 - $11.91 $12,903 - $15,066	-1,265 Reduced 8.28%	14,018 $143,000
Q3 2022 Nov 14, 2022	BUY	$11.82 - $15.42 $180,645 - $235,663	15,283 New	15,283 $199,000

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $499M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.